Paper Review Records
全部论文审稿周期
21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
4
天
Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD)
作者
Longqin Hu展开收起
作者单位
1. Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, USA; 2. The Cancer Institute of New Jersey, New Brunswick, USA展开收起
56
天
Review of promising benzimidazole-based anticancer agents (2023-2026)
作者
Elena Y. Shumilova; Sergey V. Sysolyatin; Svetlana V. Strokova展开收起
作者单位
1. Institute for Problems of Chemical and Energetic Technologies, Siberian Branch of the Russian Academy of Sciences (IPCET SB RAS), Biysk, Russia展开收起
58
天
Design, synthesis, biological activity and computational simulation evaluation of pyrimidine-2-aminoacetamide derivatives as cholinesterase inhibitors
作者
Yi-Xuan Wang; Shi-Hao Qin; Qian Liu; Xue-Wei Zhou; Chao-Yue Zhang; Zheng-Yue Ma展开收起
作者单位
1. College of Pharmaceutical Sciences, Institute of Life Science and Green Development, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, Hebei University, Baoding, China; 2. Technology Center of Shijiazhuang Customs District, Baoding, China展开收起
5
天
Zidesamtinib (Jideytro®): a new selective, brain-penetrant ROS1 inhibitor approved for the treatment of ROS1-positive non-small cell lung cancer
作者
Sumi Lee; Longqin Hu展开收起
作者单位
1. School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Republic of Korea; 2. Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, The State University of New Jersey, 160 Frelinghuy sen Road, Piscataway, Rutgers, USA; 3. The Cancer Institute of New Jersey, New Brunswick, USA展开收起
32
天
Dual-target carbonic anhydrase inhibitors in cancer therapy: progress, challenges, and opportunities
作者
Meizhen Luo; Yong Wang; Yinmei Xia; Qin-Min Wang; Jifa Zhang; Lianhai Shan展开收起
作者单位
1. School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China; 2. Department of Neurology, Laboratory of Neuro-system and Multimorbidity, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China展开收起
38
天
Enhancement of antitumor activity through structural optimization of 2-(Benzylamino)-thieno[2,3-d]pyrimidin-4(3H)-ones
作者
Nazariy Pokhodylo; Kostiantyn Levchenko; Nataliya Finiuk; Yuliia Kozak; Olha Klyuchivska; Rostyslav Stoika展开收起
作者单位
1. Ivan Franko National University of Lviv, Lviv, Ukraine; 2. Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv, Ukraine展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
